Raghav Sundar, MD, PhD, National University Cancer Institute, Singapore, Singapore, emphasizes the critical importance of data protection in oncology, particularly concerning the vast amount of patient data involved. He underscores the need for robust regulatory frameworks and guidelines, which are currently in development. Dr Sundar stresses the importance of implementing and adopting these measures globally to ensure the responsible and transparent use of artificial intelligence in clinical decision-making. This interview took place at the 2024 ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.